- Home
- HONE vs SGMO Comparison
HONE vs SGMO Comparison
Compare HONE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- SGMO
- Stock Information
- Founded
- HONE 1917
- SGMO 1995
- Country
- HONE United States
- SGMO United States
- Employees
- HONE N/A
- SGMO N/A
- Industry
- HONE Major Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HONE Finance
- SGMO Health Care
- Exchange
- HONE Nasdaq
- SGMO Nasdaq
- Market Cap
- HONE 525.1M
- SGMO 488.2M
- IPO Year
- HONE 2016
- SGMO 2000
- Fundamental
- Price
- HONE $12.07
- SGMO $1.13
- Analyst Decision
- HONE Hold
- SGMO Buy
- Analyst Count
- HONE 1
- SGMO 5
- Target Price
- HONE $13.00
- SGMO $5.20
- AVG Volume (30 Days)
- HONE 153.6K
- SGMO 10.5M
- Earning Date
- HONE 01-31-2025
- SGMO 03-12-2025
- Dividend Yield
- HONE 3.31%
- SGMO N/A
- EPS Growth
- HONE N/A
- SGMO N/A
- EPS
- HONE 0.27
- SGMO N/A
- Revenue
- HONE $158,656,000.00
- SGMO $52,291,000.00
- Revenue This Year
- HONE N/A
- SGMO N/A
- Revenue Next Year
- HONE $9.50
- SGMO $5.97
- P/E Ratio
- HONE $43.44
- SGMO N/A
- Revenue Growth
- HONE N/A
- SGMO N/A
- 52 Week Low
- HONE $9.16
- SGMO $0.30
- 52 Week High
- HONE $14.00
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- HONE 50.31
- SGMO 37.01
- Support Level
- HONE $11.79
- SGMO $1.00
- Resistance Level
- HONE $12.29
- SGMO $1.18
- Average True Range (ATR)
- HONE 0.34
- SGMO 0.15
- MACD
- HONE 0.06
- SGMO -0.04
- Stochastic Oscillator
- HONE 78.14
- SGMO 13.84
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in each of Boston, Massachusetts and Providence, Rhode Island.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.